logo

For the Inventor, By the Inventor

Budapest, Hungary

Istvan Gacsalyi

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Egis Gyogyszergyar, Egis Gyogyszergyar Rt., Basf Aktiengesellschaft. Active years: 1989-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Gacsalyi. Retrieved from https://idiyas.com/inventor/istvan-gacsalyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 90.0

 

Average Co-Inventor Count = 10.6

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal6 out of 46 
 
Egis Gyogyszergyar
 patents
silverMedal5 out of 33 
 
Egis Gyogyszergyar Rt.
 patents
bronzeMedal2 out of 10,816 
 
Basf Aktiengesellschaft
 patents
4. 1 out of 16 
 
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag
 patents
5. 1 out of 11 
 
Egis Gyogyszergyar Zrt.
 patents
6. 1 out of 1 
 
Egis Gyogyszergyat
 patent
7. 1 out of 1 
 
Egis Gyoyszergyar Rt
 patent
8. 1 out of 1 
 
Gis Gyogyszergyar Rt.
 patent
9. 2 out of 834,601 
Other
 patents

Years Active: 1989-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Dihydro-oxazinobenzodiazepine
Cognitive Function
Neuroprotection
Piperazinylalkylthiopyrimidine
Anxiolytic Agents
Heterocyclic Compounds
Pharmaceutical Compositions
Triazolo Derivatives
Bicycloheptane
Quinoline Thioethers
Dioxazocine
Styrene Derivatives
20 patents (USPTO):Explore Patents
1. 9926332 - Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them (2018-03-27),
2. 8318743 - Medicament for the enhancement of cognitive function and neuroprotection (2012-11-27),
3. 6130215 - Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions (2000-10-10),
4. 6093747 - 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents (2000-07-25),
5. 5942506 - 1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives (1999-08-24),
6. 5889018 - Heterocyclic compounds, pharmaceutical compositions comprising them and (1999-03-30),
7. 5652270 - Pharmaceutical compositions containing bicycloheptane ether amines and a (1997-07-29),
8. 5486528 - Basic ethers and process for the preparation thereof (1996-01-23),
9. 5439940 - Benz[e]indene derivatives (1995-08-08),
10. 5276030 - Triazolyl thioamide derivates (1994-01-04),
11. 5225410 - Triazolyl hydrazide derivatives (1993-07-06),
12. 5175163 - Triazolyl thioamide derivates (1992-12-29),
13. 5135928 - Triazolo derivatives and process for their preparation (1992-08-04),
14. 5071849 - Dihydropyrimidothiazine derivatives (1991-12-10),
15. 5064826 - Novel triazolo-pyrimidine derivatives (1991-11-12),

Title: Innovation Extraordinaire - Istvan Gacsalyi

Introduction:

Istvan Gacsalyi is a pioneering inventor based in Budapest, HU, with a remarkable track record in the field of pharmaceutical innovations. With an impressive portfolio of 20 patents to his name, Gacsalyi has revolutionized the healthcare industry with his groundbreaking discoveries.

Latest Patents:

Among his latest patents is the development of Dihydro-oxazinobenzodiazepine compounds, which have shown a selective dual action on the central GABAergic system. Additionally, Gacsalyi has patented a medicament aimed at enhancing cognitive function and providing neuroprotection, showcasing his commitment to advancing neurological treatments.

Career Highlights:

Gacsalyi's career is highlighted by his tenure at Egis Gyogyszergyar and Egis Gyogyszergyar Rt., where he undoubtedly made significant contributions to the pharmaceutical sector. His relentless pursuit of innovation and excellence has solidified his reputation as a leading figure in drug development.

Collaborations:

Throughout his career, Gacsalyi has collaborated with esteemed professionals in the field, including Istvan Gyertyan and Lujza E Petocz. These partnerships have not only enriched his work but have also led to the successful realization of pioneering healthcare solutions.

Conclusion:

In conclusion, Istvan Gacsalyi stands as a beacon of innovation in the realm of pharmaceuticals, with his patents reflecting his unwavering dedication to improving cognitive function and neuroprotection. His collaborative spirit and relentless pursuit of excellence underscore his invaluable contributions to the industry, making him a true trailblazer in the field of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…